• Please log in or register to access this feature.

Review Article

You have free access to this content

Genital immunology and HIV susceptibility in young women

  1. Tae Joon Yi1,
  2. Brett Shannon1,
  3. Jessica Prodger1,
  4. Lyle McKinnon1,2,
  5. Rupert Kaul1,2,*

Article first published online: 12 NOV 2012

DOI: 10.1111/aji.12035

Issue

American Journal of Reproductive Immunology

American Journal of Reproductive Immunology

Special Issue: Sexual Violence and HIV Transmission

Volume 69, Issue Supplement s1, pages 74–79, February 2013

Additional Information

How to Cite

Yi TJ, Shannon B, Prodger J, McKinnon L, Kaul R. Genital immunology and HIV susceptibility in young women. Am J Reprod Immunol 2012

Author Information

  1. 1

    Departments of Medicine and Immunology, University of Toronto, Toronto, ON, Canada

  2. 2

    Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya

* Correspondence
Rupert Kaul, University of Toronto, Medical Sciences Building, Room #6356, Toronto, ON M5S1A8, Canada.
E-mail: rupert.kaul@utoronto.ca

  1. Authors TJY and BS contributed equally to this work.

Publication History

  1. Issue published online: 6 FEB 2013
  2. Article first published online: 12 NOV 2012
  3. Manuscript Accepted: 8 OCT 2012
  4. Manuscript Received: 3 AUG 2012

Funded by

  • Canadian Institutes of Health Research. Grant Numbers: HET-85518, MOP-89983

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (100K)

References

  • 1
    Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access. In, Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011. Available at: http://www.unaids.org/en/dataanalysis/knowyourepidemic/.
  • 2
    Glynn JR, Carael M, Auvert B, Kahindo M, Chege J, Musonda R, Kaona F, Buve A: Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS 2001; 15(Suppl 4):S51–60.
  • 3
    Kenya AIDS Indicator Survey (KAIS) 2007 – Final Report, September 2009. In, National AIDS Control Council (NACC), Kenya, 2009. Available at http://www.nacc.or.ke/nacc%20downloads/official_kais_report_2009.pdf.
  • 4
    Glynn JR, Caraël M, Auvert B, Kahindo M, Chege J, Musonda R, Kaona F, Buvé A, Cities SGotHoHEiA: Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS 2001; 15(Suppl 4):S51–60.
  • 5
    Gregson S, Nyamukapa CA, Garnett GP, Mason PR, Zhuwau T, Caraël M, Chandiwana SK, Anderson RM: Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet 2002; 359:1896–1903.
  • 6
    Kelly RJ, Gray RH, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Wawer MJ: Age differences in sexual partners and risk of HIV-1 infection in rural Uganda. J Acquir Immune Defic Syndr 2003; 32:446–451.
  • 7
    Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany ABM, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D, Group obotCT: Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science 2010; 329:1168–1174.
  • 8
    Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert JH, Hayes RJ, Baeten JM, Brown J, Delany-Moretlwe S, Kaul R, McGrath N, Morrison C, Myer L, Temmerman M, van der Straten A, Watson-Jones D, Zwahlen M, Hilber AM: Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med 2011; 8:e1000416.
  • 9
    McClelland RS, Lavreys L, Hassan WM, Mandaliya K, Ndinya-Achola JO, Baeten JM: Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS 2006; 20:269–273.
  • 10
    Scorgie F, Smit JA, Kunene B, Martin-Hilber A, Beksinska M, Chersich MF: Predictors of vaginal practices for sex and hygiene in KwaZulu-Natal, South Africa: findings of a household survey and qualitative inquiry. Cult Health Sex 2011; 13:381–398.
  • 11
    Hull T, Hilber AM, Chersich MF, Bagnol B, Prohmmo A, Smit JA, Widyantoro N, Utomo ID, Francois I, Tumwesigye NM, Temmerman M: Prevalence, motivations, and adverse effects of vaginal practices in Africa and Asia: findings from a multicountry household survey. J Womens Health (Larchmt) 2011; 20:1097–1109.
  • 12
    Gallo MF, Sharma A, Bukusi EA, Njoroge B, Nguti R, Jamieson DJ, Bell AJ, Eschenbach DA: Intravaginal practices among female sex workers in Kibera, Kenya. Sex Transm Infect 2010; 86:318–322.
  • 13
    Koblin BA, Mayer K, Mwatha A, Brown-Peterside P, Holt R, Marmor M, Smith C, Chiasson MA: Douching practices among women at high risk of HIV infection in the United States: implications for microbicide testing and use. Sex Transm Dis 2002; 29:406–410.
  • 14
    Rottingen JA, Cameron DW, Garnett GP: A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001; 28:579–597.
  • 15
    Cohen MS: HIV and sexually transmitted diseases: lethal synergy. Top HIV Med 2004; 12:104–107.
  • 16
    Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ: Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. Aids 2006; 20:73–83.
  • 17
    Kaul R, Pettengell C, Sheth PM, Sunderji S, Biringer A, Macdonald K, Walmsley S, Rebbapragada A: The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol 2008; 77:32–40.
  • 18
    Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko W, Ball B, Fowke K, Mazzulli T, Plummer FA, Kaul R: Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract. Aids 2007; 21:589–598.
  • 19
    Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, Corey L: Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009; 15:886–892.
  • 20
    Datta SD, Torrone E, Kruszon-Moran D, Berman S, Johnson R, Satterwhite CL, Papp J, Weinstock H: Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis 2012; 39:92–96.
  • 21
    Weiss HA, Buvé A, Robinson NJ, Van Dyck E, Kahindo M, Anagonou S, Musonda R, Zekeng L, Morison L, Caraël M, Laga M, Hayes RJ, Cities SGoHoHEiA: The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. Aids 2001; 15(Suppl 4):S97–108.
  • 22
    Xu F, Sternberg MR, Gottlieb SL, Berman SM, Markowitz LE: Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years–United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2010; 59:456–459.
  • 23
    Batteiger BE, Xu F, Johnson RE, Rekart ML: Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis 2010; 201(Suppl 2):S178–189.
  • 24
    Hladik F, McElrath MJ: Setting the stage: host invasion by HIV. Nat Rev Immunol 2008; 8:447–457.
  • 25
    Carpenter LM, Kamali A, Ruberantwari A, Malamba SS, Whitworth JA: Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners. AIDS 1999; 13:1083–1089.
  • 26
    Hira SK, Nkowane BM, Kamanga J, Wadhawan D, Kavindele D, Macuacua R, Mpoko G, Malek M, Cruess DF, Perine PL: Epidemiology of human immunodeficiency virus in families in Lusaka, Zambia. J Acquir Immune Defic Syndr 1990; 3:83–86.
  • 27
    Padian NS, Shiboski SC, Glass SO, Vittinghoff E: Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997; 146:350–357.
  • 28
    Senkoro KP, Boerma JT, Klokke AH, Ng'weshemi JZ, Muro AS, Gabone R, Borgdorff MW: HIV incidence and HIV-associated mortality in a cohort of factory workers and their spouses in Tanzania, 1991 through 1996. J Acquir Immune Defic Syndr 2000; 23:194–202.
  • 29
    Serwadda D, Gray RH, Wawer MJ, Stallings RY, Sewankambo NK, Konde-Lule JK, Lainjo B, Kelly R: The social dynamics of HIV transmission as reflected through discordant couples in rural Uganda. AIDS 1995; 9:745–750.
  • 30
    de Vincenzi I: A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994; 331:341–346.
  • 31
    Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921–929.
  • 32
    Kigozi G, Wawer M, Ssettuba A, Kagaayi J, Nalugoda F, Watya S, Mangen FW, Kiwanuka N, Bacon MC, Lutalo T, Serwadda D, Gray RH: Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS 2009; 23:2209–2213.
  • 33
    Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC: Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149–1153.
  • 34
    Jain R, Muralidhar S: Contraceptive methods: needs, options and utilization. J Obstet Gynaecol India 2012; 61:626–634.
  • 35
    Naranbhai V, Karim SSA, Altfeld M, Samsunder N, Durgiah R, Sibeko S, Karim QA, Carr WH, team tCT: Innate Immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. J Infect Dis 2012; 206:993–1001.
  • 36
    Begaud E, Chartier L, Marechal V, Ipero J, Leal J, Versmisse P, Breton G, Fontanet A, Capoulade-Metay C, Fleury H, Barre-Sinoussi F, Scott-Algara D, Pancino G: Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 2006; 3:35.
  • 37
    Pancino G, Saez-Cirion A, Scott-Algara D, Paul P: Natural resistance to HIV infection: lessons learned from HIV-exposed uninfected individuals. J Infect Dis 2010; 202(Suppl 3):S345–350.
  • 38
    Jennes W, Evertse D, Borget MY, Vuylsteke B, Maurice C, Nkengasong JN, Kestens L: Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers. Clin Exp Immunol 2006; 143:435–444.
    Direct Link:
  • 39
    Chege D, Chai Y, Huibner S, Kain T, Wachihi C, Kimani M, Barasa S, McKinnon LR, Muriuki FK, Kariri A, Jaoko W, Anzala AO, Kimani J, Ball TB, Plummer FA, Kaul R: Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya. PLoS ONE 2012; 7:e43670.
  • 40
    Fish EN: The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008; 8:737–744.
  • 41
    Prodger JL, Gray R, Kigozi G, Nalugoda F, Galiwango R, Hirbod T, Wawer M, Hofer SO, Sewankambo N, Serwadda D, Kaul R: Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status. Mucosal Immunol 2012; 5:121–128.
  • 42
    McKinnon LR, Nyanga B, Chege D, Izulla P, Kimani M, Huibner S, Gelmon L, Block KE, Cicala C, Anzala AO, Arthos J, Kimani J, Kaul R: Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 2011; 187:6032–6042.
  • 43
    Stanley M: Early age of sexual debut: a risky experience. 2009:1–4.
  • 44
    Iwasaki A: Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol 2010; 10:699–711.
  • 45
    Blaskewicz CD, Pudney J, Anderson DJ: Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol Reprod 2011; 85:97–104.
  • 46
    Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217–223.
  • 47
    Kell PD, Barton SE, Edmonds DK, Boag FC: HIV infection in a patient with Meyer-Rokitansky-Kuster-Hauser syndrome. J R Soc Med 1992; 85:706–707.
  • 48
    Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J: Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007; 370:251–261.
  • 49
    Hladik F, Hope TJ: HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep 2009; 6:20–28.
  • 50
    Pendergrass PB, Belovicz MW, Reeves CA: Surface area of the human vagina as measured from vinyl polysiloxane casts. Gynecol Obstet Invest 2003; 55:110–113.
  • 51
    Louissaint NA, Fuchs EJ, Bakshi RP, Nimmagadda S, Du Y, Macura KJ, King KE, Wahl R, Goldsmith AJ, Caffo B, Cao YJ, Anderson J, Hendrix CW: Distribution of cell-free and cell-associated HIV surrogates in the female genital tract after simulated vaginal intercourse. J Infect Dis 2012; 205:725–732.
  • 52
    Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ, McGowan I, Margolis L, Anton P: HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 2007; 21:1263–1272.
  • 53
    Poles MA, Elliott J, Taing P, Anton PA, Chen IS: A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol 2001; 75:8390–8399.
  • 54
    Baggaley RF, White RG, Boily MC: HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010; 39:1048–1063.
  • 55
    Farage M, Maibach H: Lifetime changes in the vulva and vagina. Arch Gynecol Obstet 2006; 273:195–202.
  • 56
    Critchlow CW, Wölner-Hanssen P, Eschenbach DA, Kiviat NB, Koutsky LA, Stevens CE, Holmes KK: Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173:534–543.
  • 57
    Gray-Swain MR, Peipert JF: Pelvic inflammatory disease in adolescents. Curr Opin Obstet Gynecol 2006; 18:503–510.
  • 58
    Hwang LY, Scott ME, Ma Y, Moscicki A-B: Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. J Reprod Immunol 2011; 88:66–71.
  • 59
    Joseph Jordan AS, Howard J, Mahmood S: The Cervix, 2nd edn. Hoboken, NJ, USA, Wiley-Blackwell, 2006.
  • 60
    Ghanem KG, Shah N, Klein RS, Mayer KH, Sobel JD, Warren DL, Jamieson DJ, Duerr AC, Rompalo AM, Group HERS: Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis 2005; 191:358–366.
  • 61
    Levinson P, Kaul R, Kimani J, Ngugi E, Moses S, MacDonald KS, Broliden K, Hirbod T: Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 2009; 23:309–317.
  • 62
    Roberts L, Passmore JA, Williamson C, Little F, Naranbhai V, Sibeko S, Walzl G, Abdool Karim Q, Abdool Karim S: Genital tract inflammation in women participating in the CAPRISA TFV microbicide trial who became infected with HIV: a mechanism for breakthrough infection? (Paper # 991). In Conference on Retroviruses and Opportunistic Infections (CROI) Boston, MA, 2011. Available at: http://retroconference.org/2011/Abstracts/41472.htm.
  • 63
    Vishwanathan SA, Guenthner PC, Lin CY, Dobard C, Sharma S, Adams DR, Otten RA, Heneine W, Hendry RM, McNicholl JM, Kersh EN: High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 2011; 57:261–264.
  • 64
    Carias A, McRaven M, Anderson M, Henning T, Kersh E, Smith J, Butler K, Vishwanathan S, McNicholl JM, Hendry RM, Veazy R, Hope T: HIV interactions and the perils of epithelial thinning in the female reproductive tract. In AIDS Vaccine 2012 Boston, MA, 2012. Webcast at: http://aidsvac.capitalreach.com/console/player/19099?mediaType=audio.
  • 65
    Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, Mahoney CJ, Miller CJ, Claypool LE, Ho DD, Alexander NJ: Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996; 2:1084–1089.
  • 66
    Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM: Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012; 12:19–26.
  • 67
    Wira CR, Fahey JV: A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22:1909–1917.
View Full Article (HTML) Get PDF (100K)